Navigating the Risks and Rewards of Ozempic and Bariatric Surgery

This chapter compares Ozempic, a GLP-1 drug, with traditional weight loss methods such as bariatric surgery, evaluating their benefits and risks. It emphasizes the importance of understanding health implications and the complexities of risk-benefit analyses in addressing obesity and related metabolic diseases.